CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 74 filers reported holding CASI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $62,000 | -13.9% | 25,667 | +4.9% | 0.00% | – |
Q4 2020 | $72,000 | +323.5% | 24,466 | +120.5% | 0.00% | – |
Q3 2020 | $17,000 | -65.3% | 11,094 | -43.8% | 0.00% | – |
Q2 2020 | $49,000 | -9.3% | 19,738 | -25.2% | 0.00% | – |
Q1 2020 | $54,000 | -10.0% | 26,404 | +35.9% | 0.00% | – |
Q4 2019 | $60,000 | – | 19,430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellington Shields Capital Management, LLC | 2,188,547 | $1,751,000 | 0.22% |
Wellington Shields & Co., LLC | 1,141,190 | $913,000 | 0.18% |
Ikarian Capital, LLC | 1,223,067 | $978,000 | 0.15% |
Ground Swell Capital, LLC | 18,638 | $15,000 | 0.09% |
Anson Funds Management LP | 267,507 | $214,000 | 0.02% |
Sterneck Capital Management, LLC | 40,000 | $32,000 | 0.02% |
FEDERATED HERMES, INC. | 10,150,000 | $8,120,000 | 0.02% |
Roundview Capital LLC | 122,453 | $98,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,677,146 | $1,342,000 | 0.01% |
RBF Capital, LLC | 159,367 | $127,000 | 0.01% |